ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Prolonged grief disorder in later life: advancing our understanding of biopsychosocial mechanisms to guide future personalized interventions.
Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neuropsychiatric illness in the later years of life: summary and synthesis.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026Review
- Emotion regulation in prolonged grief disorder in later life: Protocol and rationale for a longitudinal neuroimaging study.Imaging neuroscience (Cambridge, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Grief is a near-universal yet profoundly traumatic human experience, symbolizing a testament to the depth of our emotional bonds while reminding us of life's fragility. Although most individuals adapt to loss over time, 3-10% develop Prolonged Grief Disorder (PGD), a chronic and debilitating condition recognized in both the DSM-5-TR and ICD-11. Older adults are particularly vulnerable: PGD in later life poses significant public health risks, including adverse physical health outcomes, cognitive decline, and increased premature mortality, underscoring the urgent need for early identification and effective interventions in this population. This narrative review examines psychological, social, and neurobiological perspectives on grief, highlighting distinctions between acute, integrated, and PGD trajectories. We trace the evolution of PGD as a diagnostic entity and review its risk factors, clinical presentation, comorbidities, assessment, and current treatment approaches. We then propose a neurobiological model of late-life PGD, grounded in cognitive neuroscience and emphasizing the roles of key intrinsic brain networks: the Salience Network, Default Mode Network, and Executive Control Network. Finally, we outline future directions for the field, calling for neuroimaging studies that integrate biological markers with psychosocial factors to refine diagnosis and inform targeted interventions. This review advocates for a biopsychosocial framework to advance understanding and treatment of PGD in older adults.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.